Form C Eskuad, Inc
- Wall Street mints big gains to end strong week
- JP Morgan's Kolanovic Predicts No Recession and Next Week's Rebalancing Could Drive Stocks Up 7%
- U.S. Supreme Court overturns Roe v. Wade, ends constitutional right to abortion
- FedEx (FDX) Gains on Solid FY23 Outlook, Analysts Mostly Bulled Up Into Next Week's Investors Day
- Get Ready for a 10% Rally in S&P 500
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
C 0001922582 XXXXXXXX LIVE false false true Eskuad, Inc. Corporation DE 07-27-2020 100 Fore Street First Floor Portland ME 04101 http://home.eskuad.com Y Eskuad I, a series of Wefunder SPV, LLC Limited Liability Company DE 05-20-2022 4104 24TH ST PMB 8113 San Francisco CA 94114 https://wefunder.com/ Wefunder Portal LLC 0001670254 007-00033 283503 <p>5% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.</p> No Other Simple Agreement for Future Equity (SAFE) 50000 1.00000 Pro-rated portion of the total principal value of $50,000; interests will be sold in increments of $1; each investment is convertible to one share of stock as described under Item 13. 50000.00 Y Other As determined by the issuer 250000.00 04-30-2023 5 90575.48 80.00 83830.28 0.00 80.00 80.00 3080.09 0.00 100000.00 0.00 2638.65 0.00 0.00 0.00 550.00 0.00 -32584.61 0.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY B5 GU PR VI 1V Eskuad, Inc. Max Echeverria Founder & CEO Rachael McCarthy Director 05-24-2022 Paul Michael Daoust Director 05-23-2022 Max Echeverria Founder & CEO 05-20-2022
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™
- Hertz Sponsors New Porsche Racecar to Compete in 2023 FIA World Endurance Championship
- Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!